1. Schade, David S, Shey, Lynda, Eaton, R Philip. . Cholesterol Review: A Metabolically Important Molecule. In Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 26, 1514-1523. doi:10.4158/EP-2020-0347. https://pubmed.ncbi.nlm.nih.gov/33471744/
2. Zhao, Xueyan, Li, Jiawen, Tang, Xiaofang, Song, Lei, Yuan, Jinqing. 2021. Association of NPC1L1 and HMGCR Gene Polymorphisms with Major Adverse Cardiac and Cerebrovascular Events in Patients with Three-Vessel Disease. In Human gene therapy, 32, 581-588. doi:10.1089/hum.2020.229. https://pubmed.ncbi.nlm.nih.gov/33167740/
3. Liao, Jianwei, Yang, Liyun, Zhou, Luping, Cui, Yimin, Ouyang, Dongsheng. 2022. The NPC1L1 Gene Exerts a Notable Impact on the Reduction of Low-Density Lipoprotein Cholesterol in Response to Hyzetimibe: A Factorial-Designed Clinical Trial. In Frontiers in pharmacology, 13, 755469. doi:10.3389/fphar.2022.755469. https://pubmed.ncbi.nlm.nih.gov/35359877/
4. Li, Yulong, Li, Jiawen, Tang, Xiaofang, Yuan, Jinqing, Zhao, Xueyan. 2024. Association of NPC1L1 and HMGCR gene polymorphisms with coronary artery calcification in patients with premature triple-vessel coronary disease. In BMC medical genomics, 17, 22. doi:10.1186/s12920-024-01802-0. https://pubmed.ncbi.nlm.nih.gov/38233830/
5. Liu, Yuan, Chen, Dan, Li, Jialin, Li, Li, Gan, Yong. 2019. NPC1L1-Targeted Cholesterol-Grafted Poly(β-Amino Ester)/pDNA Complexes for Oral Gene Delivery. In Advanced healthcare materials, 8, e1800934. doi:10.1002/adhm.201800934. https://pubmed.ncbi.nlm.nih.gov/30773830/
智鼠故事 
